Video
Dr. Ben Chew discusses kidney stones and metabolic syndrome
Author(s):
"Treat the patient as a whole, not just as a stone former," Chew advises.
In this interview, Ben H. Chew, MD, MSc, associate professor of urologic sciences at the University of British Columbia, Vancouver, discusses findings from the recent Journal of Endourology paper, “Metabolic Syndrome Negatively Impacts Stone-Specific Quality of Life,” for which he served as a study author.
More videos:
Dried cranberry powder shows promise in overactive bladder
Dr. Michael Albo discusses female urology training fellowships
Botulinum toxin benefits patients with adult neurogenic lower urinary tract dysfunction
Related Videos
Study results show CVAC 2.0 is safe, efficacious for wide range of kidney stones
Amir Patel, MD, on ureteral strictures following holmium vs TFL laser lithotripsy
Sarah Razavi, MD, discusses the physical toll of ureteroscopy on urologists
Joshua Heiman, MD, on phentermine plus topiramate for uric acid stone prevention
Investigators evaluate patient outcomes with silicone vs polyurethane stents
John Michael DiBianco, MD, on silicone vs polyurethane stents for patients with kidney stones
Khurshid Ghani, MD, on trial of stent omission following ureteroscopy
Endourologist discusses shared decision-making and laser lithotripsy
Ian Metzler, MD, on the role for telemedicine, digital health tools in stone disease
Perry Xu, MD, discusses PCNL’s role in the age of minimally invasive URS
Related Content
